479 related articles for article (PubMed ID: 21540587)
1. Factors influencing dialysis modality for end-stage renal disease in developing countries: a survey of Filipino nephrologists.
Cruz DN; Troidle L; Danguilan R; Padilla B; Frando L; Sebastian E; Sy-Lim A; Luz V; Finkelstein F
Blood Purif; 2011; 32(2):117-23. PubMed ID: 21540587
[TBL] [Abstract][Full Text] [Related]
2. What influences patient choice of treatment modality at the pre-dialysis stage?
Chanouzas D; Ng KP; Fallouh B; Baharani J
Nephrol Dial Transplant; 2012 Apr; 27(4):1542-7. PubMed ID: 21865216
[TBL] [Abstract][Full Text] [Related]
3. US nephrologists' recommendation of dialysis modality: results of a national survey.
Thamer M; Hwang W; Fink NE; Sadler JH; Wills S; Levin NW; Bass EB; Levey AS; Brookmeyer R; Powe NR
Am J Kidney Dis; 2000 Dec; 36(6):1155-65. PubMed ID: 11096040
[TBL] [Abstract][Full Text] [Related]
4. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis.
Kutner NG; Zhang R; Barnhart H; Collins AJ
Nephrol Dial Transplant; 2005 Oct; 20(10):2159-67. PubMed ID: 16046520
[TBL] [Abstract][Full Text] [Related]
5. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
Hashimoto Y; Matsubara T
Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease.
Alloatti S; Manes M; Paternoster G; Gaiter AM; Molino A; Rosati C
J Nephrol; 2000; 13(5):331-42. PubMed ID: 11063136
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Chinese chief nephrologists toward dialysis modality selection.
Zhao LJ; Wang T
Adv Perit Dial; 2003; 19():155-8. PubMed ID: 14763053
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting peritoneal dialysis selection in Taiwanese patients with chronic kidney disease.
Liang CH; Yang CY; Lu KC; Chu P; Chen CH; Chang YS; O'Brien AP; Bloomer M; Chou KR
Int Nurs Rev; 2011 Dec; 58(4):463-9. PubMed ID: 22092325
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.
Shahab I; Khanna R; Nolph KD
Adv Perit Dial; 2006; 22():180-5. PubMed ID: 16983966
[TBL] [Abstract][Full Text] [Related]
10. Choosing peritoneal dialysis reduces the risk of invasive access interventions.
Oliver MJ; Verrelli M; Zacharias JM; Blake PG; Garg AX; Johnson JF; Pandeya S; Perl J; Kiss AJ; Quinn RR
Nephrol Dial Transplant; 2012 Feb; 27(2):810-6. PubMed ID: 21693682
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients.
Noshad H; Sadreddini S; Nezami N; Salekzamani Y; Ardalan MR
Singapore Med J; 2009 Feb; 50(2):185-92. PubMed ID: 19296035
[TBL] [Abstract][Full Text] [Related]
12. Changing the trend: a prospective study on factors contributing to the growth rate of peritoneal dialysis programs.
Gadallah MF; Ramdeen G; Torres-Rivera C; Ibrahim ME; Myrick S; Andrews G; Quin A; Fang C; Crossman A
Adv Perit Dial; 2001; 17():122-6. PubMed ID: 11510258
[TBL] [Abstract][Full Text] [Related]
13. What do American nephologists think about dialysis modality selection?
Mendelssohn DC; Mullaney SR; Jung B; Blake PG; Mehta RL
Am J Kidney Dis; 2001 Jan; 37(1):22-29. PubMed ID: 11136163
[TBL] [Abstract][Full Text] [Related]
14. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
16. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives.
Juergensen E; Wuerth D; Finkelstein SH; Juergensen PH; Bekui A; Finkelstein FO
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1191-6. PubMed ID: 17699347
[TBL] [Abstract][Full Text] [Related]
17. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
Goovaerts T; Jadoul M; Goffin E
Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
[TBL] [Abstract][Full Text] [Related]
18. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
[TBL] [Abstract][Full Text] [Related]
20. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
